Governments and industry must work together to implement fundamental changes in the molybdenum-99 (Mo-99) supply chain to ensure long-term reliability of supply, the OECD's Nuclear Energy Agency (NEA) has said. The OECD/NEA steering committee for nuclear energy said disruptions in the global supply chain of Mo-99 and its decay product technetium-99m (Tc-99m) over the past two years have had significant impact on patients, who have had important diagnostic tests cancelled or delayed. Mo-99 and Tc-99m are the most widely used medical radioisotopes, used in medical diagnostic imaging techniques that enable accurate and early detection of diseases such as heart conditions and cancer.
展开▼
